Walleye Trading’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Walleye Trading’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,500	Closed	-$250K	–	4311
2020 Q2	$296K	Buy	1,500 +151	+11%	+$31.3K	﹤0.01%	2730
2020 Q1	$264K	Buy	+1,349	New	+$290K	﹤0.01%	2388
2016 Q4	–	Sell	-800	Closed	-$52K	–	4867
2016 Q3	$52K	Buy	+800	New	+$45.1K	﹤0.01%	3734
2016 Q1	–	Sell	-200	Closed	-$13K	–	5507
2015 Q4	$13K	Sell	200 -300	-60%	-$15.3K	﹤0.01%	4632
2015 Q3	$20K	Buy	+500	New	+$28.8K	﹤0.01%	4074

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Walleye Trading's LKFT Position: Q3 2020 in Review

Walleye Trading sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 1,500 shares — an estimated $250K sold.

Walleye Trading first reported a position in LKFT in Q3 2015 and held it in 5 quarters. The position peaked at $296K in Q2 2020. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

Walleye Trading reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Walleye Trading sold 1,500 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $250K.
Walleye Trading first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and held it in 5 quarters.
Walleye Trading's Lakefront Biotherapeutics American Depositary Shares position peaked at $296K in Q2 2020.
119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on Walleye Trading's 13F filing for Q3 2020, filed 16 Nov 2020.